NEO
NeoGenomics, Inc.Data: 2026-10-02
Quick Stats
Oct 02, 202628.4
AI Score
AVOID NEW MONEY1.13
Volume Ratio
Oct 27, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
NEO Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
NEO Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
NEO Options - Sort by Max open Interest (near term)
3rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NEO Daily Out of Money Options - Sort by Max open Interest (near term)
3rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NEO Daily In the Money Options - Sort by Max open Interest (near term)
3rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NEO Most Active Options by Volume(near term)
3rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NEO Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NEO Stock Summary
Last updated Oct 02, 2026
NEO is currently trading at $18.47, positioned above its 200-day moving average of $12.32, indicating a long-term uptrend. The stock has a 52-week range of $7.065 to $20.0499.
Technical Analysis: The 50-day moving average stands at $17.2, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 52.306, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.065, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NEO at 28.4/100 with a AVOID NEW MONEY recommendation.
NEO (NeoGenomics, Inc.) Indicators
Last updated Oct 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 52.306 |
| CMF (20) | -0.065 |
| ROC (10) | -7.233 |
| ADX (14) | 36.195 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.38 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -68.397 |
| MFI (14) | 51.178 |
NEO Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Oct 02 | Gap Three Methods (bearish) (contrarian — textbook says the opposite) | Bullish | 56.1% | +3.0 pts | 4558 |
| Oct 01 | Inverted Hammer | Bullish | 56.4% | +3.4 pts | 19834 |
| Sep 28 | Inverted Hammer | Bullish | 56.4% | +3.4 pts | 19834 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
NeoGenomics, Inc. is above both the 50 Day and 200 Day SMA which is considered Bullish.
NEO Moving Averages Analysis
NeoGenomics, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Oct 02, 2026
NeoGenomics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Oct 02, 2026
NEO (NeoGenomics, Inc.) Simple Moving Averages
Moving Averages are last updated Oct 02, 2026
| Days | MA |
|---|---|
| 10 | 18.82 |
| 20 | 18.59 |
| 30 | 18.21 |
| 50 | 17.2 |
| 100 | 14.54 |
| 200 | 12.32 |
NEO Fundamental Analysis
| P/E (Forward) | 222.2222 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.3 billion |
| Earnings/Share ($) | -0.38 |
| Net Profit Margin (%) | -0.0677 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.1827 |
| EPS Estimate Next Year ($) | 0.3382 |
| WallStreet Target Price ($) | 19.72 |
| Most Recent Quarter |
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.